A retrospective analysis assessed MGMT expression (by immunohistochemistry) in archival NET specimens and compared the prevalence of MGMT deficiency in pancreatic NETs and extra-pancreatic NETs [48]. The gene discussed is MGMT; the disease is pancreatic neuroendocrine tumor.